SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells.

被引：0

作者：

Jain, Nayan ^{[1
]}

Zhao, Zeguo ^{[1
]}

Koche, Richard ^{[1
]}

Gozlan, Yosi ^{[2
]}

Brocks, David ^{[2
]}

Raveh-Sadka, Tali ^{[2
]}

Wells, Danny ^{[3
]}

Dobrin, Anton ^{[1
]}

Shi, Yuzhe ^{[1
]}

Lopez, Michael ^{[1
]}

Gunset, Gertrude ^{[1
]}

Sadelain, Michel ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY USA

[2] Immunai, Tel Aviv, Israel

[3] Immunai, San Francisco, CA USA

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5583

引用

页数：1

共 50 条

[1] SUV39H1 disruption imparts functional persistence to CD28-costimulated human CAR T cells
Jain, Nayan
Zhao, Zeguo
Koche, Richard
Gozlan, Yosi
Brocks, David
Raveh-Sadka, Tali
Wells, Danny
Dobrin, Anton
Shi, Yuzhe
Lopez, Michael
Gunset, Gertrude
Sadelain, Michel
JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
[2] Optimization of CD28-Costimulated CARs for Increased Anti-Tumor Activity and Persistence
Guedan, Sonia
Posey, Avery D.
Wing, Anna
Casado-Medrano, Victoria
Shaw, Carolyn
Young, Regina
June, Carl H.
MOLECULAR THERAPY, 2018, 26 (05) : 299 - 299
[3] Deleting SUV39H1 in CAR-T cells epigenetically enhances the antitumor function
Wang, Yuning
Zhao, Guo
Wang, Shuhang
Li, Ning
MEDCOMM, 2024, 5 (05):
[4] Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability
Guedan, Sonia
Madar, Aviv
Casado-Medrano, Victoria
Shaw, Carolyn
Wing, Anna
Liu, Fang
Young, Regina M.
June, Carl H.
Posey, Avery D., Jr.
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (06): : 3087 - 3097
[5] Mixed Signals: Alteration of CD28 Signaling Motifs Improves Anti-Tumor Efficacy and Persistence of CAR T Cells
Posey, Avery D.
Guedan-Carrio, Sonia
Kawalekar, Omkar U.
Shaw, Carolyn
Wing, Anna
June, Carl H.
MOLECULAR THERAPY, 2017, 25 (05) : 154 - 154
[6] SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Lopez-Cobo, Sheila
Fuentealba, Jaime R.
Gueguen, Paul
Bonte, Pierre-Emmanuel
Tsalkitzi, Kyriaki
Chacon, Irena
Glauzy, Salome
Bohineust, Armelle
Biquand, Ariane
Silva, Lisseth
Gouveia, Zelia
Goudot, Christel
Perez, Franck
Saitakis, Michael
Amigorena, Sebastian
CANCER DISCOVERY, 2024, 14 (01) : 120 - 141
[7] CD28-costimulation provided through a CD19-specific chimeric immunoreceptor enhances in vivo persistence and anti-tumor efficacy of adoptively transferred T cells.
Kowolik, CM
Gonzalez, S
Olivares, S
Jensen, M
Cooper, LN
BLOOD, 2005, 106 (11) : 372A - 372A
[8] Enhancing the Persistence and Anti-Tumor Efficacy of CAR-T and CAR-NK Cells through Genetic Disruption of Death Receptors
Cohen, Tal Dror
Yi, Fei
Zumbo, Paul
Etilib, Razan
Arkin, Hannah
Gormally, Michael, V
Hackett, Christopher S.
Kropp, Korbinian
Etxeberria, Inaki
Chandran, Smita S.
Park, Jae H.
Betel, Doron
Klebanoff, Christopher
TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (02):
[9] BLOCKADE OF CD95/CD95L PATHWAY ENHANCES CAR T CELL PERSISTENCE AND ANTI-TUMOR EFFICACY IN VITRO AND IN VIVO
He, Bailin
Scheller, Marina
Wang, Lei
Neuber, Brigitte
Schmitt, Anita
Hofmann, Susanne
Mueller-Tidow, Carsten
Schmitt, Michael
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 224 - 224
[10] CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
Leticia Laura Niborski
Paul Gueguen
Mengliang Ye
Allan Thiolat
Rodrigo Nalio Ramos
Pamela Caudana
Jordan Denizeau
Ludovic Colombeau
Raphaël Rodriguez
Christel Goudot
Jean-Michel Luccarini
Anne Soudé
Bruno Bournique
Pierre Broqua
Luigia Pace
Sylvain Baulande
Christine Sedlik
Jean-Pierre Quivy
Geneviève Almouzni
José L. Cohen
Elina Zueva
Joshua J. Waterfall
Sebastian Amigorena
Eliane Piaggio
Nature Communications, 13

← 1 2 3 4 5 →